Community/Retail

Research suggests that subcutaneous insulin aspart is a cost-effective and accessible treatment option that could allow children with type 1 diabetes to avoid the ICU after a mild episode of diabetic ketoacidosis.

The long-acting, once-daily hormone controls high blood sugar in individuals aged 1 year or older with diabetes.

Research indicates that poor technique or failure to follow up-to-date standards and protocols could lead to injury or even death of patients who need compounded medications.

Key responsibilities include providing recommendations, administering vaccinations, disseminating evidence-based advice, reducing spread of influenza in communities.

Excess drinking is a major atrial fibrillation risk factor in young people.

ADvocate 1 and ADvocate 2 are 52-week randomized, double-blind phase 3 studies designed to evaluate lebrikizumab as monotherapy in adult and adolescent patients with moderate to severe AD.

It is currently indicated for the treatment of adult patients with active psoriatic arthritis and adult patients with oral ulcers associated with Behçet's Disease.

The New Drug Application for aripiprazole 2-month, ready-to-use, long-acting injectable could lead to the first FDA approval of a 2-month schizophrenia and bipolar I disorder antipsychotic treatment.

Research suggests that non-traditional complications from type 2 diabetes are hospitalizing more people now than they did 20 years ago.

This week, Joanna speaks with Lydia Fenet, ambassador at Christie’s Auction House and best-selling author of The Most Powerful Woman in the Room is You, to discuss the professional side of wellness.

Although OTC medications are generally considered safe when used as directed, there are some key drug interactions for pharmacists to keep in mind when helping patients choose an OTC product.

Boehringer Ingelheim’s monoclonal antibody inhibits interleukin-36 (IL-36) signaling and is the first treatment specifically approved for this indication.

Modification is based on phase 3 FIGARO-DKD clinical trial investigating CV and kidney outcomes in more than 13,000 patients with CKD associated with type 2 diabetes.

Surveys show that 70% of migraine sufferers are not satisfied with their current acute treatment regimen.

Decision is based on interim analysis of Pfizer’s GBS6 in healthy pregnant woman aged 18 to 40 years, who were vaccinated during their second or early third trimesters.

Analysis presented at an American Heart Association meeting suggests that following DASH is most effective to reduce the risk of heart attacks and strokes.

Deucravacitinib (Sotyktu) may become the new standard of care oral therapy for moderate-to-severe plaque psoriasis, according to investigators.

Although serotonin is widely associated with feelings of happiness, a study suggests it may be associated with the severity of COVID-19.

A refundable state-level earned income tax credit was associated with a 21% reduction in high-risk HIV behavior among low-income women last year, suggesting that policy can reduce this burden.

Researchers expect to file for FDA approval within the year following the successful phase 3 trial.

Receiving 3 doses of the COVID-19 vaccine can offer better and more long-lasting protection against the Omicron variant.

The findings also indicate that that treatment may have protective CV and limb benefits for those with kidney failure and concomitant peripheral artery disease.

Viral antigen levels in blood plasma can provide clinically important patient outcomes among hospitalized patients with COVID-19.

Because there is no vaccine for the disease, preventive strategies are needed, investigators from Copenhagen University Hospital in Denmark say.

Prescription drug monitoring programs have decreased prescription opioids in the United States but resulted in unintended spikes of illegal drug use and heroin-related deaths.

The percentage of infections, hospitalizations, and deaths that were prevented from COVID-19 vaccination increased with greater vaccine coverage, according to a recent study.

Dupilumab is used as a maintenance therapy when added to other asthma medications.

Dual GIP/GLP-1 agonist therapy demonstrated superior glucose control and weight loss in patients with diabetes compared to selective GLP-1 receptor agonists in preclinical and clinical trials.

Children younger than age 6 years might be protected from other COVID-19 variants for up to a year after infection.

Pharmacists handle public vaccination efforts and need to assess where patients are on the hesitancy spectrum to provide reliable information.